Trial · NCT01280201
Adverse events30
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 30
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | HEPATOTOXICITY | Hepatobiliary disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | DIABETIC DECOMPENSATION | Endocrine disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | INTESTINAL SUBOCLUSION | Gastrointestinal disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | HYPERGLUCEMIA | Metabolism and nutrition disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | GENERALIZED CRISIS | Psychiatric disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | OBSTRUCTIVE ICTERY | Hepatobiliary disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | OLIGOARTRALGIAS | Musculoskeletal and connective tissue disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | HYPERTENSIVE CRISIS | Vascular disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | RESPIRATORY INFECTION BY E.COLI | Infections and infestations | Arm of Pazopanib | 1 | 44 | 1 |
| serious | ACTIVE TUBERCULOSIS | Infections and infestations | Arm of Pazopanib | 1 | 44 | 1 |
| serious | CEREBELLY HEMATOMY | Vascular disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | ALT AND AST INCREASE | Hepatobiliary disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | CELLULITIS | Skin and subcutaneous tissue disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | DISSEMINATED INTRAVASCULAR COAGULATION | Vascular disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | COLANGITIS | Hepatobiliary disorders | Arm of Pazopanib | 1 | 44 | 3 |
| serious | COMA HYPOGLYCEMIC | Metabolism and nutrition disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | Dysphagia | Gastrointestinal disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | ABDOMINAL PAIN | General disorders | Arm of Pazopanib | 1 | 44 | 1 |
| serious | TUMORAL PAIN | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Arm of Pazopanib | 1 | 44 | 1 |
| serious | HEPATIC ENCEPHALOPATHY | Hepatobiliary disorders | Arm of Pazopanib | 1 | 44 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01280201/events